医学
观察研究
竖脊肌
回顾性队列研究
外科
麻醉
不利影响
腰痛
背痛
筋膜
肌电图
术后疼痛
背部手术失败
随机对照试验
慢性疼痛
可视模拟标度
队列研究
作者
Giorgio Pirrotta,Giuliano Lo Bianco,Bruno Giuseppe Gioia,Benedetta La Barbera,Giuseppe Natoli,Roberta Di Maggio,Alaa A Abd-Elsayed,Agnes Reka Stogicza,Michael E Schatman,Christopher Louis Robinson,Pasquale Enea
出处
期刊:Pain Practice
[Wiley]
日期:2026-10-03
卷期号:26 (8): e70198-e70198
摘要
BACKGROUND: Chronic low back pain (CLBP) is frequently associated with dysfunction of the erector spinae (ES) muscles and thoracolumbar fascia (TLF), increasingly recognized as contributors to pain through altered biomechanics, fibrosis, and impaired fascial gliding. Ultrasound-guided hydrodissection has emerged as a minimally invasive technique to restore interfascial mobility and reduce nociceptive input. Evidence regarding higher dextrose concentrations and selective hydrodissection of the ES fascial compartments remains limited. OBJECTIVE: To evaluate the safety and clinical effectiveness of ultrasound-guided ES hydrodissection using 10% dextrose in patients with CLBP, and to compare outcomes between surgical and non-surgical patients. METHODS: This retrospective observational study included 40 patients with CLBP (> 3 months) localized to the ES muscles. All patients underwent three ultrasound-guided hydrodissection sessions at 14-day intervals using 10% dextrose with lidocaine. Pain intensity (NRS), functional disability (ODI), and muscle quality (Heckmatt score) were assessed at baseline and up to 3 months follow-up. RESULTS: Mean NRS decreased from 7.58 to 3.27 at 3 months (-56.9%). Mean ODI improved from 54.00 to 27.82 (-46.4%). Non-surgical patients showed greater improvements in pain (-82.5%) and disability (-74.9%) compared to post-surgical patients (-39.4% and -33.5%, respectively). No significant adverse events were observed. CONCLUSIONS: Ultrasound-guided ES hydrodissection with 10% dextrose is a safe and effective treatment for CLBP, producing clinically meaningful reductions in pain and disability, particularly in non-surgical patients. Further controlled studies are warranted to confirm long-term efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI